BUB1 and pancreatic ductal adenocarcinoma: Elevated BUB1 expression correlates with aggressive phenotypes and unfavorable prognosis in various cancers, such as pancreatic ductal adenocarcinoma, breast cancer, glioblastoma, and papillary thyroid cancer [61–64].